These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 18692805

  • 1. Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study.
    Kaya C, Cengiz SD, Berker B, Demirtaş S, Cesur M, Erdoğan G.
    Fertil Steril; 2009 Aug; 92(2):635-42. PubMed ID: 18692805
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: A prospective, randomized study.
    Kaya C, Pabuccu R, Cengiz SD, Dünder I.
    Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):161-6. PubMed ID: 20146169
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease.
    Oktem M, Ozcimen EE, Uckuyu A, Esinler I, Pamuk B, Bayraktar N, Kulaksizoglu S, Zeyneloglu HB.
    Fertil Steril; 2009 Jun; 91(6):2545-50. PubMed ID: 18554599
    [Abstract] [Full Text] [Related]

  • 5. Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome.
    Carlsen SM, Kjøtrød S, Vanky E, Romundstad P.
    Acta Obstet Gynecol Scand; 2007 Jun; 86(2):145-50. PubMed ID: 17364275
    [Abstract] [Full Text] [Related]

  • 6. C-reactive protein and homocysteine levels are associated with abnormal heart rate recovery in women with polycystic ovary syndrome.
    Kaya C, Akgül E, Pabuccu R.
    Fertil Steril; 2010 Jun; 94(1):230-5. PubMed ID: 19362308
    [Abstract] [Full Text] [Related]

  • 7. Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial.
    Kilicdag EB, Bagis T, Tarim E, Aslan E, Erkanli S, Simsek E, Haydardedeoglu B, Kuscu E.
    Hum Reprod; 2005 Jun; 20(6):1521-8. PubMed ID: 15790610
    [Abstract] [Full Text] [Related]

  • 8. The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
    Gul OB, Somunkiran A, Yucel O, Demirci F, Ozdemir I.
    Arch Gynecol Obstet; 2008 Jan; 277(1):25-30. PubMed ID: 17618446
    [Abstract] [Full Text] [Related]

  • 9. Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study.
    Mancini F, Cianciosi A, Reggiani GM, Facchinetti F, Battaglia C, de Aloysio D.
    Fertil Steril; 2009 Jun; 91(6):2537-44. PubMed ID: 18462732
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of supraphysiologic doses of testosterone on fasting plasma total homocysteine concentrations in men with Klinefelter's syndrome.
    Yesilova Z, Ozata M, Oktenli C, Sanisoglu SY, Erbil MK, Dagalp K.
    Fertil Steril; 2004 May; 81(5):1278-82. PubMed ID: 15136090
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
    Ludwig AK, Goharian LG, Dietze T, Tauchert S, Rudolf S, Diedrich K, Schweiger U, Oltmanns KM.
    Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
    [Abstract] [Full Text] [Related]

  • 15. Dietary intervention with emphasis on folate intake reduces serum lipids but not plasma homocysteine levels in hyperlipidemic patients.
    Lim HJ, Choi YM, Choue R.
    Nutr Res; 2008 Nov; 28(11):767-74. PubMed ID: 19083486
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial.
    Bayar U, Basaran M, Kiran S, Coskun A, Gezer S.
    Fertil Steril; 2006 Nov; 86(5):1447-51. PubMed ID: 17070196
    [Abstract] [Full Text] [Related]

  • 19. The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Keleş T, Akar Bayram N, Kayhan T, Canbay A, Sahin D, Durmaz T, Ozdemir O, Aydoğdu S, Diker E.
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):407-12. PubMed ID: 19103535
    [Abstract] [Full Text] [Related]

  • 20. Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment.
    Glintborg D, Andersen M, Richelsen B, Bruun JM.
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):652-8. PubMed ID: 19170716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.